Market Update:Overview of Performance of Australian Markets. S&P/ASX200 Closed In Green

As the market players are aware, trade battle between the US and China could affect the performance of broader Australian economy and can also weigh over the performance of Australian equities. In the event of slowdown, investors liquidate their holdings in equities largely because of the risks associated with this asset class. We would now have a look at how markets performed on October 10, 2019.

S&P/ASX200 index ended the session in green, as there was an increase of 0.4 points and, as a result, the session closed at 6547.1. On the other hand, on the same day, All Ordinaries ended in red, due to a fall of 4.1 points or 0.1% on an intraday basis, closing the session at 6662.9.

On October 10, 2019, CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV) and Resolute Mining Limited (ASX: RSG) also ended the session in red, posting a decline of 14.756% and 11.228%, respectively, in their share price.

Recently, we have written about Rafaella Resources Limited (ASX: RFR) and to view please click here.

Stock of ORA Rose 13.919% On Intraday Basis

Orora Limited (ASX: ORA) announced to have entered into a binding agreement to sell its Australasian Fibre Business. The sale would be made to the wholly owned subsidiary of Nippon Paper Industries Co., Limited for an enterprise value amounting to A$1,720 million. In the market update, the company mentioned that after the receipt of interest for Australasian Fibre Business, the Board of Orora has concluded that Nippon Paper offer is compelling and offer acceptance is in the best interests of shareholders. As per the release dated October 10, 2019, ORA anticipates receiving the net cash proceeds as a result of transaction, after taxes, transaction costs, restructuring costs as well as customary closing adjustments amounting to A$1,550 million.

After the completion of transaction, ORA has intention to return in vicinity of A$1,200 million, being majority of the net proceeds, to the shareholders, in most efficient way with the help of capital management initiatives.

We would now have a look at how the stock of ORA performed on October 10, 2019. ORA ended the session in green, as the stock witnessed a rise of 13.919% to end at A$3.110 per share.

Brambles Releases Trading Update For First Quarter

Sales revenue from continuing operations of Brambles Limited (ASX: BXB) amounted to US$1,159.0 million for the first three months of financial year ending 30 June 2020 (FY 2020), which implies a rise of 5% at the constant FX rates as well as an increase of 2% at the actual FX rates. The difference between actual and constant FX growth implies strengthening of the Brambles’ reporting currency, the USD, relative to all the other operating currencies, as per the result update.

On October 10, 2019, the stock price of Brambles Limited ended the session in green, growing 3.542% and settling at A$11.400 per share.

ORA Daily Technical Chart (Source: Thomson Reuters)


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report